AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + proprietary hiring database

✓Executive contact details included

INDUSTRY FIRST

Faeth Therapeutics Appoints Dr. Stephen Hahn As Chief Medical Executive and Dr. Jayson Dallas As Chief Executive Officer

Nov 22, 2024•9 months ago

Position

Chief Executive Officer

Company

Faeth Therapeutics

Dr. Jayson Dallas

Description

Faeth Therapeutics strengthens its leadership team with the appointment of Dr. Stephen Hahn, a renowned radiation oncologist and former Chief Medical Executive of MD Anderson Cancer Center, and Dr. Jayson Dallas, an accomplished biotech leader and former CEO of Aimmune Therapeutics, to its Board of Directors

Company News

(6 articles)

Tue, 13 May 2025 07:00:00 GMT

Faeth Therapeutics Shows Preclinical Proof-of-Concept for Drug-Diet Combination to Treat Cancer, in Peer-Reviewed Publication - Business Wire

Thu, 30 Jun 2022 07:00:00 GMT

Faeth Therapeutics raises $47 million to advance clinical trials and feed the fight against cancer - PR Newswire

Fri, 22 Nov 2024 08:00:00 GMT

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors - citybiz

Wed, 17 Jul 2024 07:00:00 GMT

Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase - Business Wire

Wed, 12 Mar 2025 07:00:00 GMT

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

Fri, 22 Nov 2024 08:00:00 GMT

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors - Business Wire

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months